Doctor Qing Liu

Ruijin Hospital, Shanghai (China)

Membership: ESC Professional Member

Follow

Contributor content

Influence of baseline Hb1Ac and antiplatelet therapy on 5-year clinical outcomes after coronary artery bypass grafting.

Presentation

Influence of baseline Hb1Ac and antiplatelet therapy on 5-year clinical outcomes after coronary artery bypass grafting.

ESC 365 is supported by

novartis

Explore sponsored resources